1 / 19

La Raison d’etre pour AIMBE

La Raison d’etre pour AIMBE. Raphael C. Lee, MD, ScD, DSc(Hon), FACS President, AIMBE. What is AIMBE?. Provides leadership and advocacy in medical and biological engineering for the benefit of society. Founded in 1991 282 Founding Fellows (1992-1993) Current membership includes:

margot
Download Presentation

La Raison d’etre pour AIMBE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. La Raison d’etre pour AIMBE Raphael C. Lee, MD, ScD, DSc(Hon), FACS President, AIMBE

  2. What is AIMBE? Provides leadership and advocacy in medical and biological engineering for the benefit of society. • Founded in 1991 • 282 Founding Fellows (1992-1993) • Current membership includes: • College of Fellows • Academic Council • Council of Societies • Industry Council • AIMBE Represents – 50,000Biomedical Engineers

  3. What does AIMBE Do? A vehicle for input of biomedical engineering expertise into public policy making process: AIMBE: • Promotes awareness of medical and biological engineering as a resource to solve common problems • Works with lawmakers, government agencies, and other professional groups to support public policy impacting research and development • Promotes the national interest in education, science, and engineering

  4. MBE and the Quality of Life of Americans

  5. AIMBE: Fostering Innovation Field of Medical and Biological Engineering Industry AIMBE Community Academia Entrepreneur Collaboration among Industrial, Academic, and Entrepreneurial members of AIMBE’s Industry Council and Government guides science and technology translation from the medical and biological engineering community. FDA NIH Legislative Branch Executive Branch CDC NSF

  6. Timeline HR 1795 introduced Passes House AIMBE Resolution Passes Senate NIH Revitalization Bill Signed into Law NIH Report: Support for Bioengineering Research AIMBE Founded 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 Dr. ShuChien letter in Science Legislative Failures AIMBE & ARRS form Coalition

  7. NIH Budget vs FDA approvals

  8. Productivity of the Pharmaceutical Industry 50 60 R&D Expenditures Approvals 50 40 40 30 R&D Spending (US$ Billions) 30 NMEs and Biologics Approved 20 20 10 10 1995 2000 2005 Sources: FDA/CDER, PhRMA, PricewaterhouseCoopers Note: R&D spending from non-PhRMA companies not available

  9. Five Public Policy Issues Affecting Biomedical Engineering • Spiraling R&D costs coupled with decreased productivity • Demand for safety and post-marketing surveillance • Expectation of personalized medicine • Reimbursement driven by medical and economic outcomes • Proliferation and redistribution of healthcare outcomes information

  10. Asia Pacific Rim Success In Technology Industrialization • People with strong sense of national purpose • Strong investments in education and training • Strategy to move rapidly up value chain • Effective requirements for training and tech transfer • Critical mass in R&D is beginning to be deployed to generate autonomous sources of innovation & growth • Government goal is to acquire technological capabilities both to grow and to maintain national autonomy. • Focused, Committed, and Willing to Spend Modified from C. Dahlman, Georgetown University

  11. Why is advocacy important?

  12. Why must INFORMED scientists be involved in legislation ? BME Congress

  13. Federal Agencies with AIMBE Links

  14. MBE’s Impact on the U.S. Economy • 10.3% growth in net sales in 2008 compared to 5.9% growth in sales for the rest of the economy • 2008: health care and social assistance industries increased GDP by 4.6% • Total GDP attributed to health care expenditures: $2.3 trillion (2008) • MBE-specific exports lead imports, which increases national income

  15. Grand Challenges for Mankindfrom Nobel Laureate Richard Smalley: 1943-2005 Bioengineering related • ENERGY • WATER • FOOD • ENVIRONMENT • POVERTY • TERRORISM & WAR • DISEASE • EDUCATION • DEMOCRACY • POPULATION 2004 6.5 Billion People 2050 ~ 10 Billion People

  16. AIMBE American Institute for Medical and Biological Engineering 1701 K St., NW, Suite 510 Washington, DC 20006 Phone: 202-496-9660

  17. The Valley Of Death Valley of Death Existing Research Resources Existing Commercialization Resources Idea Research Fuzzy Front End Product Development Commercialization From:The PDMA ToolBook 1 for New Product Development

  18. Re-engineering Pharmaceutical R&D “It is not the strongest of the species that survives, nor the most intelligent, but the one most responsive to change.” Charles Darwin (1809-1882) Illustration from The World Is Flat, Thomas L. Friedman, Farrar, Straus & Giroux, publisher

  19. The Cycle of Innovation and Translational Research

More Related